Divergent androgen regulation of unfolded protein response pathways drives prostate cancer

Xia Sheng, Yke Jildouw Arnoldussen, Margrethe Storm, Martina Tesikova, Hatice Zeynep Nenseth, Sen Zhao, Ladan Fazli, Paul Rennie, Bjørn Risberg, Håkon Wæhre, Håvard Danielsen, Ian G Mills, Yang Jin, Gökhan Hotamisligil, Fahri Saatcioglu

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)
205 Downloads (Pure)


The unfolded protein response (UPR) is a homeostatic mechanism to maintain endoplasmic reticulum (ER) function. The UPR is activated by various physiological conditions as well as in disease states, such as cancer. As androgens regulate secretion and development of the normal prostate and drive prostate cancer (PCa) growth, they may affect UPR pathways. Here, we show that the canonical UPR pathways are directly and divergently regulated by androgens in PCa cells, through the androgen receptor (AR), which is critical for PCa survival. AR bound to gene regulatory sites and activated the IRE1α branch, but simultaneously inhibited PERK signaling. Inhibition of the IRE1α arm profoundly reduced PCa cell growth in vitro as well as tumor formation in preclinical models of PCa in vivo. Consistently, AR and UPR gene expression were correlated in human PCa, and spliced XBP-1 expression was significantly upregulated in cancer compared with normal prostate. These data establish a genetic switch orchestrated by AR that divergently regulates the UPR pathways and suggest that targeting IRE1α signaling may have therapeutic utility in PCa.

Original languageEnglish
Pages (from-to)788-801
Number of pages14
JournalEMBO Molecular Medicine
Issue number6
Early online date11 Apr 2015
Publication statusPublished - 01 Jun 2015


Dive into the research topics of 'Divergent androgen regulation of unfolded protein response pathways drives prostate cancer'. Together they form a unique fingerprint.

Cite this